Trials / Completed
CompletedNCT06180473
Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream
Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream in Patients With Psoriasis Previously Treated With Enstilar Foam.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess with the PPQ questionnaire the patient preference for Wynzora compared with therapy carried out previously with Enstilar spray foam. Secondary objectives Assess satisfaction with the treatment. Assess adherence to therapy. Evaluate the impact of various clinical and demographic factors on treatment adherence. Evaluate the efficacy of Wynzora cream therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | PPQ, TTAQ PTCS |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-03-31
- Completion
- 2024-06-30
- First posted
- 2023-12-22
- Last updated
- 2025-09-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06180473. Inclusion in this directory is not an endorsement.